Journal Article Summary
The article investigates the use of preconceptual folic acid supplementation and the counseling on recurrence risk for congenital heart disease (CHD) among families with a history of the condition. This topic is significant because families with a first-degree relative affected by CHD have a higher risk of having another child with the same condition compared to the general population. The study aims to identify how often at-risk mothers engage in folic acid supplementation before conception and whether they receive adequate counseling regarding the recurrence risk of CHD.
The researchers enrolled pregnant mothers referred for fetal echocardiograms, categorizing them into two groups: those at higher risk of having a child with CHD (cases) and those without obvious prenatal risk factors (controls). A total of 314 mothers participated, with findings indicating that those in the at-risk group were more likely to start folic acid supplementation before pregnancy compared to the control group. However, a notable percentage of at-risk mothers still began supplementation later than recommended or did not take it at all. Additionally, while many at-risk mothers reported receiving counseling about recurrence risk, few engaged with genetic services for more detailed information.
The study has limitations, including a potential bias since participants were referred to a specialized center, which may not reflect the broader population of at-risk families. The sample size was relatively small, and there could be recall bias in the responses regarding counseling received. Patients and caregivers should discuss these findings with healthcare professionals, particularly pediatricians and cardiologists, to ensure they receive comprehensive information about the benefits of preconceptual folic acid use and the importance of understanding recurrence risks associated with CHD.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Peyvandi Shabnam, Rychik Jack, Zhang Xuemei, Shea Judy A, Goldmuntz Elizabeth. Preconceptual Folic Acid Use and Recurrence Risk Counseling for Congenital Heart Disease. Congenital heart disease 2014. DOI: 10.1111/chd.12206. PMID: 25059817. PMCID: PMC4762601.
Featured Pill Pals Product
Folic Acid 1 mg Tablets --- Generic For Folvite --- Modavar
Folic Acid 1 mg Tablets — Generic For Folvite — Modavar is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
